Authors:
Rothenberg, ML
Kuhn, JG
Schaaf, LJ
Rodriguez, GI
Eckhardt, SG
Villalona-Calero, MA
Rinaldi, DA
Hammond, LA
Hodges, S
Sharma, A
Elfring, GL
Petit, RG
Locker, PK
Miller, LL
von Hoff, DD
Citation: Ml. Rothenberg et al., Phase I dose-finding and pharmacokinetic trial of irinotecan (CPT-11) administered every two weeks, ANN ONCOL, 12(11), 2001, pp. 1631-1641
Citation: S. Hodges, Express warranties of seaworthiness in time policies: A comparative analysis of American and English law, J MAR LAW C, 32(1), 2001, pp. 95-133
Authors:
Kim, J
Palmer, JL
Finn, L
Hodges, S
Bowes, V
Deftos, L
Murphy, G
Logothetis, C
Citation: J. Kim et al., The pattern of serum markers in patients with androgen-independent adenocarcinoma of the prostate, UROL ONCOL, 5(3), 2000, pp. 97-103
Authors:
Hackel, CG
Krueger, S
Grote, HJ
Oshiro, Y
Hodges, S
Johnston, DA
Johnson, ME
Roessner, A
Ayala, AG
Czerniak, B
Citation: Cg. Hackel et al., Overexpression of cathepsin B and urokinase plasminogen activator is associated with increased risk of recurrence and metastasis in patients with chondrosarcoma, CANCER, 89(5), 2000, pp. 995-1003
Authors:
Czerniak, B
Chaturvedi, V
Li, L
Hodges, S
Johnston, D
Ro, JY
Luthra, R
Logothetis, C
Von Eschenbach, AC
Grossman, HB
Benedict, WF
Batsakis, JG
Citation: B. Czerniak et al., Superimposed histologic and genetic mapping of chromosome 9 in progressionof human urinary bladder neoplasia: implications for a genetic model of multistep urothelial carcinogenesis and early detection of urinary bladder cancer, ONCOGENE, 18(5), 1999, pp. 1185-1196
Citation: S. Hodges, The character of leadership: Political realism and public virtue in nonprofit organizations, J COLL STUD, 40(6), 1999, pp. 757-758
Authors:
Drengler, RL
Kuhn, JG
Schaaf, LJ
Rodriguez, GI
Villalona-Calero, MA
Hammond, LA
Stephenson, JA
Hodges, S
Kraynak, MA
Staton, BA
Elfring, GL
Locker, PK
Miller, LL
Von Hoff, DD
Rothenberg, ML
Citation: Rl. Drengler et al., Phase I and pharmacokinetic trial of oral irinotecan administered daily for 5 days every 3 weeks in patients with solid tumors, J CL ONCOL, 17(2), 1999, pp. 685-696